Atlas Trials

Study of Ofatumomab in Combination With ICE-chemotherapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL)

Clinical trial NCT02412267 · COMPLETED

Trial details

NCT number
NCT02412267
Sponsor
National Cancer Centre, Singapore
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diffuse Large B-cell Lymphoma
Start date
2011-04-01
Primary completion
2015-12-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.